Serum miR-122 and Human Genomic DNA in Patients With Drug-Induced Acute Liver Failure or With Chronic Hepatitis C

function. Daidzein increased BrdU incorporation to ~30% and prevented hyperbilirubinemia in mice subjected to IR+PHX. While all mice survived after PHX, survival decreased to ~13% after IR+PHX. Daidzein increased survival after IR+PHX to ~88%.Conclusion. Suppression of MB after IR+PHX plays an important role in inhibition of liver regeneration and function. MB is a novel therapeutic target to improve the outcome of MLR (NIDDK).